A Comparison of Post-Sternotomy Dressings

Not Applicable

Completed

• Conditions: Impaired Wound Healing; Postoperative Wound Infection-deep
• Interventions: Other: Metallic Silver Dressing; Other: Dry Sterile Dressing; Other: Ionic Silver Dressing

• Registration Number: NCT02198066
• Lead Sponsor: Carilion Clinic

Brief Summary

The purpose of this study was to determine which of three types of dressings, a dry sterile dressing, a metallic silver dressing or an ionic silver dressing provided better patient outcomes for the post-sternotomy cardiac surgery patient population. In this prospective, randomized controlled trial, the hypothesis was that subjects who received either of the silver impregnated dressings would have better outcomes (better wound healing, less discomfort, and less incidence of infection). Investigators also evaluated dressing factors such as adherence, time for application and ease of use.

Detailed Description

No other information included.

Study Timeline

• Study Start: 2010-07
• Primary Completion: 2012-08
• Study Completion: 2012-08
• Status Verified: 2014-03
• Study First Submitted: 2014-03-27
• Study First Submitted QC: 2014-07-21
• Last Update Submitted: 2014-07-21
• Study First Posted: 2014-07-23
• Last Update Posted: 2014-07-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 351

Inclusion Criteria

• Adult (at least 21 years of age) inpatients awaiting cardiac surgery or outpatients seen in the pre-surgical testing area prior to admission for surgery
• Having surgery at the study setting
• English-speaking
• Able to understand and give consent
• Had the approval of their cardiothoracic surgeon to participate
• Had no known sensitivity to silver
• Had no known sensitivity to alginates

Exclusion Criteria

• Known sensitivity to silver
• Known sensitivity to alginates

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Metallic Silver Dressing	Metallic Silver Dressing	Subjects in this arm received a metallic silver dressing (Acticoat Post-Op®, Smith \& Nephew), a one-piece, peel-and-stick and non-transparent dressing. This dressing is an absorbent postoperative dressing consisting of a nanocrystalline silver-coated polyurethane layer, a white polyurethane foam and an adhesive coated waterproof polyurethane film layer. Acticoat Post-Op may be left in place over a wound for up to 7 days. The manufacturers note that the product should not be used in patients with known silver allergies and that it may cause transient discoloration of the skin.
Dry Sterile Dressing	Dry Sterile Dressing	Subjects in this study arm received a dry sterile dressing (Primapore®, Smith \& Nephew), a one-piece, peel-and-stick, non-transparent dressing. This dressing is the standard of care at the study facility for this population and was left in place for either 24 to 48 hours.
Ionic Silver Dressing	Ionic Silver Dressing	Subjects in this arm received an ionic silver dressing (Dermanet Ag®, DeRoyal), a semi-transparent dressing that includes silver, alginate, and maltodextrin. The dressing was cut to fit the incision and then covered with a transparent dressing (Transseal®, DeRoyal). This dressing should not be used on patients with known sensitivity to alginates (a seaweed based component).

Primary Outcome Measures

Name	Time	Method
Wound Healing	5 days postoperatively or day of discharge, whichever came first	The primary outcome measure in this study was wound healing, defined as the degree of wound approximation, skin integrity, exudate, and presence/absence of necrotic tissue, assessed at postoperative day 5 or day of discharge. Wound approximation was assessed as total, partial (less than 2 centimeters of superficial separation), moderate (greater than 2 centimeters of superficial separation), or dehisced (complete separation of layers). Skin integrity was evaluated as normal (pink, no redness), inflamed, (heat, redness, swelling), or macerated within a 2.5 centimeter border of the incision. Exudate quality was assessed as purulent, blood, serosanguinous, or serous. Presence or absence of necrotic tissue was noted.

Secondary Outcome Measures

Name	Time	Method
Patient Comfort	5 days postoperatively or day of hospital discharge, whichever came first	The secondary outcome measure in this study was patient comfort with the dressing in place and upon removal. Comfort was measured using a 0-10 scale, with 0 signifying no pain and 10 signifying maximum pain.

Trial Locations

Locations (1)

Carilion Roanoke Memorial Hospital; 🇺🇸 Roanoke, Virginia, United States